A patented unique strain of Lactococcus lactis (LC-Plasma)
Type: Postbiotics
Application: Supplement & Nutrition
Comprehensive Immune Activation
IMMUSE™ is a novel postbiotic which is a patented strain of Lactococcus lactis that provides clinically researched immune support*. A strong immune system is crucial to maintaining good health. Today’s consumers face a constant onslaught on their immune systems from the stresses of modern life, work, diet and other lifestyle factors. With a unique mechanism of action that activates pDC (plasmacytoid dendritic cells), IMMUSE™ is a novel solution for your next immunity product.
IMMUSE™ Earns Frost & Sullivan 2021 New Product Innovation Award
Add IMMUSE™ to your next product
Contact us for product information
Related News
Kyowa Hakko USA Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
May 19, 2022NEW YORK (PRWEB)With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP. Read more »
Kyowa Hakko USA Announces the Appointment of Dr. Heather Moday as an Educational Partner for IMMUSE™ LC-Plasma
May 12, 2022NEW YORK (PRWEB)With a special interest in immune system dysfunction, including autoimmunity, allergy, and the stress-immune connection, Dr. Moday puts IMMUSE™, an award-winning postbiotic, at the forefront of ingredients to look out for in nutritional supplements. Read more »
Copyright © 1998 – 2022 by KYOWA HAKKO U.S.A., INC. All Rights Reserved.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.